GS-5885 (Ledipasvir)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GS-5885 (Ledipasvir), covering 2013-12-20 to 2014-02-03. Get the full timeline:
Most recent: Clinical Trial Update: GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype [Phase 2]